Sign in to view content

Baseline Ellipsoid Zone Integrity Features as Predictors of Geographic Atrophy Growth Rate in the Phase 3 GATHER Clinical Trials

Katherine E Talcott, MD

Video
Published 2024

Related

Beyond Complement: A Novel FAS Inhibition Approach for Neuroprotection in GA
Vaidehi S. Dedania, MD
Updates from the Field
2024
A Descriptive Analysis of Patients Who Received Pegcetacoplan and Anti-VEGF for the Treatment ofGeographic Atrophy and Neovascular AMD
Nimesh A. Patel, MD
Annual Meeting Talks
2025
Clinical and Demographic Factors Associated With Loss to Follow-up in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Durga Borkar, MD
Annual Meeting Talks
2021

Category: AMD-Non-Neovascular

See more